News
12h
Verywell Health on MSNIs Methylene Blue Really a Brain Booster? Here's What Pharmacologists SaySome biohackers are experimenting with methylene blue as a supposed anti-aging and brain-enhancing supplement, but experts ...
Bristol Myers Squibb (BMY) is pushing for Reblozyl’s label expansion despite tough competition and generic pressures.
10h
Court TV on MSNCO v. James Craig: Poisoned Shake Murder TrialA Colorado dentist accused of poisoning his wife’s protein shakes is on trial for murder. James Craig is facing multiple charges, including first-degree murder, for the death of 43-year-old Angela ...
The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...
21h
ScienceAlert on MSNCOVID Can Cause Alzheimer's-Like Plaques in Eyes And BrainIn a new study led by Yale University, researchers sought to illuminate apparent similarities between COVID brain fog and ...
Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results